Go Ad-Free
logoThe People's Perspective on Medicine

Bump in the Road for Beta Blockers

Beta blockers are among the most trusted and most prescribed drugs in the pharmacy. Medications such as atenolol (Tenormin), metoprolol (Lopressor, Toprol) and the granddaddy of them all, propranolol (Inderal) have been taken by tens of millions of patients for decades.

Initially, beta blockers were developed to treat chest pain and lower blood pressure. They are also used to control irregular heart rhythms. The scientist who developed propranolol, Sir James Black, was honored with the 1988 Nobel Prize for medicine because of this drug discovery.

After more than 40 years as a mainstay for the treatment of hypertension, beta blockers are losing their luster. The Cochrane Collaboration is an independent, highly regarded organization of outside experts who review the world’s evidence on drugs.

A recent analysis concludes that, “Beta-blockers are not recommended as first line treatment for hypertension as compared to placebo due to their modest effect on stroke and no significant reduction in mortality or coronary heart disease” (Cochrane Database of Systematic Reviews, Nov. 14, 2012).

What will have doctors scratching their heads in disbelief is a study in the Journal of the American Medical Association (JAMA, Oct. 3, 2012). The investigators tracked 44,708 high-risk heart patients. These people had had a heart attack or were diagnosed with coronary artery disease. After roughly 44 months of follow-up, there was no evidence beta blockers prevented second heart attacks, strokes or death due to cardiovascular causes.

Beta blockers may still be helpful immediately after a heart attack, but long-term use appears less beneficial than previously believed. And side effects can be daunting.

Beta blockers can make breathing more difficult, especially for people who are susceptible to asthma. Other complications may include fatigue, dizziness, slow heart rate, depression, sleep disturbances, hair loss, digestive upset, weakness and sexual dysfunction.

No one must ever stop a beta blocker suddenly, however. Doing so could trigger chest pain, irregular heart rhythms or even a heart attack.

Many physicians will find the new research challenging. According to the authors of the JAMA study, in 2010 nearly 34 million prescriptions were written for atenolol alone.

Patients taking such drugs as first-line treatments for high blood pressure may need to ask their doctors about other options. The authors of the Cochrane report suggest that some other types of medications such as diuretics, calcium antagonists or ACE inhibitors may be more effective for preventing premature death.

To learn more about this controversial topic and the pros and cons of various other therapies, we offer our Guide to Blood Pressure Treatment. Patients on beta blockers should ask their doctors to review the latest research from the JAMA and Cochrane to determine whether such drugs are still appropriate.

Rate this article
star-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-empty
4.2- 5 ratings
About the Author
Joe Graedon is a pharmacologist who has dedicated his career to making drug information understandable to consumers. His best-selling book, The People’s Pharmacy, was published in 1976 and led to a syndicated newspaper column, syndicated public radio show and web site. In 2006, Long Island University awarded him an honorary doctorate as “one of the country's leading drug experts for the consumer.”.
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.